Literature DB >> 25092457

Mapping of HPV transcripts in four human cervical lesions using RNAseq suggests quantitative rearrangements during carcinogenic progression.

Jinmiao Chen1, Yuezhen Xue2, Michael Poidinger1, Thimothy Lim3, Sung Hock Chew3, Chai Ling Pang1, Jean-Pierre Abastado4, Françoise Thierry2.   

Abstract

Two classes of Human papillomaviruses (HPV) infect the anogenital track: high risk viruses that are associated with risk of cervical cancer and low risk types that drive development of benign lesions, such as condylomas. In the present study, we established quantitative transcriptional maps of the viral genome in clinical lesions associated with high risk HPV16 or low risk HPV6b. Marked qualitative and quantitative changes in the HPV16 transcriptome were associated with progression from low to high grade lesions. Specific transcripts encoding essential regulatory proteins such as E7, E2, E1^E4 and E5 were identified. We also identified intrinsic differences between the HPV6b-associated condyloma transcript map and that of the HPV16-associated low grade CIN specifically regarding promoter usage. Characterization and quantification of HPV transcripts in patient samples thus establish the impact of viral transcriptional regulation on the status of HPV-associated lesions and may therefore help in defining new biologically-relevant prognosis markers.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; HPV; Patient samples; Promoter usage; Quantification; RNAseq; Transcripts

Mesh:

Year:  2014        PMID: 25092457     DOI: 10.1016/j.virol.2014.05.026

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.

Authors:  Francesca Paolini; Gianfranca Curzio; Marcelo Nazario Cordeiro; Silvia Massa; Luciano Mariani; Fulvia Pimpinelli; Antonio Carlos de Freitas; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

2.  Characterization of the Human Papillomavirus 16 E8 Promoter.

Authors:  Elke Straub; Jasmin Fertey; Marcel Dreer; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

3.  HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma.

Authors:  Yuezhen Xue; Shen Yon Toh; Pingping He; Thimothy Lim; Diana Lim; Chai Ling Pang; Jean-Pierre Abastado; Françoise Thierry
Journal:  Oncotarget       Date:  2015-10-27

Review 4.  Deciphering the Multifactorial Susceptibility of Mucosal Junction Cells to HPV Infection and Related Carcinogenesis.

Authors:  Michael Herfs; Thing R Soong; Philippe Delvenne; Christopher P Crum
Journal:  Viruses       Date:  2017-04-20       Impact factor: 5.048

5.  5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.

Authors:  Adrien Morel; Aurélie Baguet; Jérôme Perrard; Caroline Demeret; Elise Jacquin; David Guenat; Christiane Mougin; Jean-Luc Prétet
Journal:  Oncotarget       Date:  2017-07-11

6.  Increased expression of PD‑L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity.

Authors:  Chaoqi Liu; Jiao Lu; Huiqun Tian; Wei Du; Lin Zhao; Jing Feng; Ding Yuan; Zhiying Li
Journal:  Mol Med Rep       Date:  2017-01-05       Impact factor: 2.952

Review 7.  Control of human papillomavirus gene expression by alternative splicing.

Authors:  Sheila V Graham; Arwa Ali A Faizo
Journal:  Virus Res       Date:  2016-11-17       Impact factor: 3.303

Review 8.  The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis.

Authors:  Leslie Olmedo-Nieva; J Omar Muñoz-Bello; Adriana Contreras-Paredes; Marcela Lizano
Journal:  Viruses       Date:  2018-01-18       Impact factor: 5.048

9.  RNA-Seq Analysis of Differentiated Keratinocytes Reveals a Massive Response to Late Events during Human Papillomavirus 16 Infection, Including Loss of Epithelial Barrier Function.

Authors:  T Klymenko; Q Gu; I Herbert; A Stevenson; V Iliev; G Watkins; C Pollock; R Bhatia; K Cuschieri; P Herzyk; D Gatherer; S V Graham
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

Review 10.  Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation.

Authors:  Sheila V Graham
Journal:  Viruses       Date:  2017-08-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.